When patient-derived melanoma cells harboring a BRAFWT/NRASQ61K driver mutation (BAK parental cells; BAKP) were magnetically sorted into CD133(+) and CD133(−) subpopulations, CD133 expression in the CD133(+) cells diminished after two weeks of subculture. This evidence concerns the gene PROM1 and melanoma.